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The eosinophil cationic protein (ECP), a potent helminthotoxin with considerable ncurotoxic a tivity, was recently shown to also have ribonucleo- 
lytic activity. In this work the substrate preference ofECP ribonuclcase ction was tudied in detail. With singe-stranded RNA or synthetic polyri- 
bonucleotide substrates ECP showed significant but low activity, 70. to 200-fold less than that of bovine RNase A. ECP hydrolyzed .RNA more 
rapidly than it did any synthetic polynucleotide. Poly(U) was degraded more rapidly than poly(C), and poly(A) and double-stranded substrates 
were cxtrcmely resistant. &fined low molecular weight substrates in the form of the 16 dinucleoside phosphates (NpN’) and uridine and cytidine 
2’, 3’-cyclic phosphates were tested, and none showed hydrolysis by ECP at a significant rate. The results link ECP ribonucleolytic activity to the 
‘non-secretory’ liver-type nzymes rather than to the ‘secretory’ pancreatic-type RNases. 
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1, INTRODUCTION 
Human eosinophil granules contain several basic pro- 
teins with unusual biological activities. Two of these 
proteins, the eosinophil derived neurotoxin (EDN) and 
the eosinophil cationic protein (ECP), are particularly 
well characterized. Both proteins were initially isolated 
as neurotoxins [l], but their relationship to 
ribonucleases became obvious upon determination of 
partial amino acid sequences [1,2] and their comparison 
with the amino acid sequences of human ‘secretory’ and 
‘non-secretory’ RNases isolated from human pancreas 
[3] or urine [4] and liver [S]. Full nucleotide sequences 
of cDNAs for EDN and ECP have now been determin- 
ed [6-91 and it is clear that EDN is identical to liver 
RNase. In addition, the structure and chromosomal 
location of the EDN and ECP genes have been reported 
[lOI. 
There is thus clear evidence that both EDN and ECP 
are products of very related genes in the RNase gene 
superfamily. Both proteins show similar neurotoxic 
potency [I], although the assay is not easily quan- 
titated. ECP is the more potent helminthotoxin [ 11,121, 
while EDN possesses 50-100 times more ribonucleolytic 
activity than ECP [ 13,141. The substrate specificity and 
preference of EDN and liver RNase have already been 
compared with each other and with bovine RNase A 
[lS], and Iwama et al. [16] have studied these 
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characteristics of the human urinary RNase Us which is 
probably the same protein. This work examines in 
detail the RNase activity of ECP with a variety of 
sinple- and double-stranded polynucleotides, 
dinucleoside phosphates, and 2 ’ ,3 ’ -cyclic nucleotides 
as substrates. 
2. MATERIALS AND METHODS 
2. I. Materials 
ECP, purified from human eosinophil granules as previously 
described [I], was the generous gift of Dr Gerald Gleich. Bovine pan- 
creatic RNase A (type XII-A) and bovine serum albumin were pur- 
chased from Sigma. Wheat germ high molecular weight RNA and 
bacteriophage f2 RNA were prepared according to published pro- 
cedures [17,18]. Yeast RNA, sin@- and double-stranded 
polynucleotidcs, dinucleoside monophosphates and nucleosidcs 
2 ’ .3’ -cyclic phosphates were all Sigma products. 
2.2. Ennzynre assays 
Ribonuclease activity against wheat germ RNA was measured 
through the formation of perchloric acid.solubIe nucleotides as 
described [18] except that the reaction buffer contained 0.05 M 
4-morpholinopropanesulphonic acid (MOPS), pH 7.5, and bovine 
serum albumin (I mgl’ml). Activity with a yeast RNA substrate (fur- 
thcr purified from the commercial product as described by Blackburn 
et al. 1191) was measured at pH 5.0 and 7.5 following the Kunitz 1201 
assay procedure. Degradation of single- and double-stranded syn- 
thctic polynucl*:otidc substrates and of bacteriophage f2 RNA was 
followed spcctrophotomctrically in a variation of a previously 
described proccdurc [21,22], Enzyme activity with dinuclcosidc 
phosphate substrates (NpN’), was measured by a modification of the 
method of Witzcl and Barnard 1231 while hydrolysis of cytidinc and 
uridinc 2’,3’-cyclic phospharcs was assayed by modificntions of the 
proccdurcs of Crook et al. (24) and Richards [25], respectively. 
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2.3. Thermal transition proJiles of nucleic acids 
Thermal transition profiles of poly(dA-dT):poly(dA-dT) were 
measured in the presence and absence of RNases. Measurements were 
made at 260 nm in thermostatically controlled stoppered cuvettes 
(Starna Ltd, London, type 29) with a Zeiss PM6 spectrophotometer. 
In all experiments he concentration of the polynuclcotide was about 
IO~g/ml (initial absorbance at 260 nm, 0.210); RNase, if present, was 
also 10 &ml (Atso. about 0.005-0.008). 
3. RESULTS AND DISCUSSION 
The major human ribonucleases, although part of the 
ribonuclease superfamily of related proteins, have been 
grouped into two broad classes [26] usually designated 
‘secretory’ and ‘non-secretory’. The former are most 
abundant in secretory organs and body fluids including 
pancreas, prostate, seminal fluid, milk, and saliva [27]; 
they are sometimes classed as ‘pancreatic-type en- 
zymes. They show a marked substrate preference for 
poly(C) rather than poly(U) and, under specific condi- 
tions, a pH optimum near 8.0 for RNA degradation. 
The non-secretory or ‘liver type’ enzymes predominate 
in liver and spleen and are minor components of urine 
and serum [27]. These enzymes how a pH optimum 
near 7.0 with RNA as substrate, and hydrolyze poly(U) 
more readily than poly(C). 
ECP is a secreted protein with a typical 27 amino acid 
putative signal peptide [7]. However, its deduced amino 
acid sequence shows 70% identity to human non- 
secretory RNase/EDN [4-71. It is therefore of interest 
to determine whether the catalytic characteristics of 
ECP link it to either category of RNase. 
As a measure of the substrate specificity of ECP as a 
ribonuclease, its action on three different natural RNA 
types and several different single- and double-stranded 
synthetic polyribonucleotide substrates was measured 
using different assay conditions and methods. As 
shown in Table I, ECP-catalyzed hydrolysis of all 
single-stranded polynucleotides was slow relative to 
that of bovine RNase A; the bovine enzyme was 70-200 
times as active with RNA and poly(U) substrates, and 
more than 3000 times as active on poly(C). These data 
are in agreement with some previous results [13,141 ob- 
tained with RNA substrates. Beintema [28] and Barker 
et al. [7] have recently suggested that the low 
ribonucleolytic activity of ECP could be linked to its 
lack of a basic residue at sites equivalent to either posi- 
tion 66 or 122 of the protein (using the pancreatic 
RNase sequence numbering system). 
ECP showed no measurable ribonuclease activity 
against poly(A) or the double-stranded substrates po- 
ly(A):poly(U) or poly(I):poly(C); EDN/liver RNase is 
also inactive with these polymers [15]. The inability of 
ECP to attack double-stranded substrates i correlated 
with its lack of helix-destabilizing activity, as shown in 
Fig. 1. Although ECP is a very basic protein [7], the 
data of Fig. 1 show that it is not able to disrupt the 
structure of double-stranded poly(dA-dT) under condi- 
tions of both high and low ionic strength. Helix 
destabilizing activity was considered to be one of the 
factors that favors RNase attack on double stranded 
polynucleotides 1221. For example, human seminal 
RNase, a basic secretory enzyme that is very similar if 
not identical to human pancreatic ribonuclease [29] and 
which degrades double-stranded polynucleotides 
400-500 times faster than RNase A, shows marked 
helix-destabilizing activity [22,30]. 
The relative preference of human ECP for various 
macromolecular substrates is summarized and com- 
pared with other human RNases in Table II. It is clear 
that ECP RNase activity most resembles tha,L of the 
non-secretory liver type enzymes. In particular, HCP is 
most active on an RNA substrate, and prefers poiy(U) 
to poly(C) by a factor of four while the pancreatic type 
enzymes prefer poly(C) over all other substrates and po- 
ly(U) is degraded relatively slowly. It is worth noting 
that the pofy(U) preference of ECP is due to a marked 
Table I 
Activity of human ECP on polymeric substrates compared with that of bovine RNase A 
Substrate Assay pH Method ECP RNase A RNasc A 
(U/mg) (U/m& ECP 
Wheat Germ RNA 7.5 “Acid soluble A260 2170 356000 164 
Yeast RNA 5.0 bHypochromicity 1.3 95 71 
7.5 9, 2.4 47s 198 
Phagc f2 RNA 7.0 ‘Hyperchromicity 125 7940 63 
Poly(U) 7.0 ,I 12.2 890 73 
POlYK) 7.0 9, 3.1 13300 4290 
Poly(A) 7,o II n,d. 0.13 - 
Poly(A,U) 7,o I, 232 16600 71 
Poly(A,C) 7.0 ,t 205 26000 I26 
Poly(A):Poly(U) 7.0 II n.d. 2.9 - 
Poly(l):Poly(C) 7.0 ,* n.d. 30.2 - 
’ U defined in [18). b U defined In (201. c U calculated OS: (chahgc in A&min)/total measurable 
change in Aswo; substrate (OS1 mM in phosphate) plus on appropriate amount of cnzymc were mixed 
III I ml of 0. I M 4.morpholinocthancsulphonic acid (MB), pH 7.0,O. I M NaCI, at 25T. Each value 
is the average of duplicate c!:tcrminatlons; n.d.: not dctcctcd, 
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Fig. 1. Effect of human Eosinophil Cationic Protein or bovine RNase A on the thermal transition profile of double-stranded poly(dA-dT):poly(dA- 
dT) under different ionic conditions. In 1 ml of 10 mM MOPS buffer (pH 7) containing 20 mM NaCl (a), 50 mM NaCi (b), 100 mM NaCl (c). 
IOpg of the double-stranded polymer were mixed with IOpg of bovine RNase A (A), or ECP (0); (O), thermal transition profile of the nucleic 
acid in the absence of protein. 
Table II 
Substrate preference of human ECP compared with those of human pan- 
creatic and liver ribonucleases 
Enzyme Ratio of substrate cleavage 
RNA/Poly(C) RNA/Poly(U) Poly(c)/Poly(u) 
ECP 408 10” 0.25= 
Pancreatic RNase 0.3s 8b 2Gb 
Liver RNase 167b 12b 0.07b 
’ Calculated from Table 1; b Calculated from [5] 
decrease in the ability of the protein to degrade poly(C) 
rather than an absolute or relative increase in the rate of 
poly(U) hydrolysis; the ratio of RNA/poly(U) 
hydrolysis rates is similar for both enzyme types. These 
results also partially contradict he claim of Gullberg et 
al. [14] that ECP shows no substrate specificity. 
However, their paper does not present data to support 
this statement, and it is our observation that any such 
conclusion must be based on quantitation of initial 
cleavage rates of both polymeric and dinucleoside 
phosphate substrates. 
With defined low molecular weight substrates ECP 
showed no measurable ribonuclease activity. None of 
the sixteen dinucleoside phosphates (NpN ‘) and neither 
uridine and cytidine 2’ ,3’-cyclic phosphates was 
degraded at an appreciable rate by ECP under the con- 
ditions used; in each assay bovine RNase A was includ- 
ed as a positive control on the method used. Again this 
is characteristic of the non secretory class of RNases 
which have been found to degrade dinucleoside 
phosphates very slowly and to be virtually inactive in 
the hydrolysis of nucleoside 2’ ,3 ’ -cyclic phosphates 
[ 15,161. This inactivity with small substrates may be due 
in part to the absence of an aromatic residue (Phe or 
Tyr) at the site equivalent to position 120 of the bovine 
RNase A sequence; in human angiogenin the replace- 
ment of leucine by phenylalanine at this position in- 
creases the activity of this protein against small 
substrates up to lOO-fold [31]. 
All of the nucleolytic characteristics of ECP 
presented here serve to link this protein to the ‘non- 
secretory’ or liver type RNases [26]. These observations 
further emphasize the confusion generated by use of the 
terms secretory and non-secretory when all members of 
the RNase gene superfamily encode signal peptides 
[10,32] which may lead to secretion or to localization in 
lysosomes. Perhaps designation of ECP as a liver type 
RNase or, as suggested by Maddalena et al. [33], as a 
member of the RNase IIu subclass is more logical. 
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